IMMUNOTHERAPY ADVANCES Impact Score 2026

---

The latest ranking of IMMUNOTHERAPY ADVANCES has been released. Through this web page, researchers can check the ranking, journal quartile, and journal aim & scope.

IMMUNOTHERAPY ADVANCES: Aim & Scope

IMMUNOTHERAPY ADVANCES is a indexed journal tha publishes research in the area: Immunology and Microbiology.
The ISSN of this journal is 27324303.

Impact Score of IMMUNOTHERAPY ADVANCES

Journal Title	Immunotherapy Advances
Impact Score	7.6
SJR	1.504
ISSN	27324303
Quartile	Q2

Similiar journals to publish

---

Therapeutic Advances in Vaccines and Immunotherapy

ISSN: 2515-1363
Journal Impact:
Journal Scope: Drug Discovery (Q2); Immunology and Allergy (Q2); Oncology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)

IMMUNOTHERAPY ADVANCES

ISSN: 2732-4303
Journal Impact: 4.1
Journal Scope: Immunology

Journal of Immunotherapy and Precision Oncology

ISSN: 26662345, 2590017X
Journal Impact:
Journal Scope: Immunology and Allergy (Q3); Oncology (Q3); Cancer Research (Q4); Immunology (Q4)

Journal for Immunotherapy of Cancer

ISSN: 2051-1426
Journal Impact: 10.3
Journal Scope: Oncology | Immunology

Cancer Immunology, Immunotherapy

ISSN: 14320851
Journal Impact:
Journal Scope: Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1)

Journal of Immunotherapy

ISSN: 15374513
Journal Impact: 3.2
Journal Scope: Oncology | Immunology | Medicine, Research & Experimental

Immunotherapy

ISSN: 1750-7448
Journal Impact: 2.7
Journal Scope: Immunology

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

ISSN: 2167-9436
Journal Impact:
Journal Scope: Immunology (Q4); Immunology and Allergy (Q4)

Trends in Immunotherapy

ISSN: 25735985
Journal Impact:
Journal Scope: Pharmacology (medical) (Q3); Immunology (Q4); Immunology and Allergy (Q4); Oncology (Q4)

CANCER IMMUNOLOGY IMMUNOTHERAPY

ISSN: 1432-0851
Journal Impact: 4.6
Journal Scope: Oncology | Immunology